TRANSVAC Training Modules 📖 🔬🐁
OPEN CALL | Submit your application for TRANSVAC Courses now
In brief: This course is designed to critically discuss the design of animal studies: choice of animal models, presentation of less frequently used animal species, animal numbers and the extrapolation of results to humans.
Where? Wageningen University, The Netherlands
When? 12-13 March 2020
M6 Cytometry by time of flight CyTOF
In brief: Cytometry by time of flight (CyTOF) or mass cytometry allows the simultaneous detection of multiple phenotypic markers at the single cell level. You can learn a theory and practice of mass-cytometry applied to assessing the immune response in human and animal models.
Where? CEA, France
When? 4-5 March 2020
M8 In vivo Imaging
To be introduced to multimodal in vivo imaging from the basic principles including basics in biophysics, methodologies for in vivo imaging, to image analysis and biological interpretation of the results.
Where? CEA, France
When? 2-4 March 2020
⏳ Apply here until November 15th, 2019
TRANSVAC Vaccine Development Services 🧫🧪🧬
OPEN CALL | Submit your application for TNA services now
TRANSVAC2 project offers high-quality technical services to support the development of prophylactic and therapeutic vaccines for both human and animal use.
- These services are not restricted to any disease in particular.
- Services will be offered free of charge, with few exceptions!
- Academic and non-academic research groups, SMEs and industries can apply but only to service infrastructures outside their own country.
⏳ Apply here until December 15th, 2019
📣 New partnership with ERINHA-Advance allows TRANSVAC users to apply with projects studying highly infectious pathogens.
The first TNA Call to ERINHA’s full catalogue of services, including access to cutting edge high containment facilities was also launched on October 15th, 2019. The following pathogens are prioritized within this call: Ebola virus, Marburg virus, Lassa virus, Crimean Congo Hemorrhagic Fever virus and Nipah virus.
Applicants with interest in highly pathogenic agents and vaccine development are encouraged to apply to both calls.